Recent progress in vitiligo treatment might be heading to vitiligo cureAugust 23, 2019Pigmentation DisordersMedical Dermatology
Topical ruxolitinib looks good for facial vitiligo, in phase 2 studyJune 26, 2019Pigmentation DisordersMixed Topics
Timolol shortens propranolol use in infantile hemangiomaJune 4, 2019DermatologyPediatricsPigmentation Disorders
Topical calcineurin inhibitors prove beneficial for patients with vitiligoJune 3, 2019Pigmentation Disorders
Whether diet, vitamins, or supplements can benefit patients with vitiligo remains unclearMarch 18, 2019Pigmentation DisordersDermatology
Depigmentation therapy may be appropriate for patients with vitiligoMarch 2, 2019Pigmentation Disorders
Trametinib effectively treats case of giant congenital melanocytic nevusFebruary 21, 2019DermatologyPigmentation DisordersPediatrics
Bidirectional relationship found between depression, vitiligoJanuary 18, 2019DepressionPigmentation DisordersDermatologyMental Health
Many devices optimal for treating vascular skin lesionsSeptember 14, 2018Pigmentation DisordersAesthetic DermatologyMixed Topics
Extended propranolol use boosts success in high-risk infantile hemangiomaSeptember 8, 2018Pigmentation DisordersDermatologyPediatrics
Orodental issues often associated with facial port-wine stainsAugust 29, 2018DermatologyPediatricsPigmentation DisordersMedical Dermatology
Pediatric vitiligo primarily affects those aged 10-17July 29, 2018DermatologyPediatricsPigmentation Disorders
New analysis improves understanding of PHACE syndromeJuly 12, 2018DermatologyPediatricsPigmentation Disorders
